Apple and Quest Diagnostics Partner to Integrate Lab Orders in Health App

Key Facts

1Apple Health app users in the U.S. will be able to purchase and receive results for over 50 biomarkers from Quest Diagnostics directly in the app.

In a move reflecting the strategic expansion of digital health services, Quest Diagnostics has announced a partnership with Apple to allow users in the United States to order lab tests directly via the Health app. According to reports, iPhone and iPad users will be able to purchase and receive results for over 50 biomarkers securely within the app, aiming to provide a more convenient way to manage health data and access testing services.

This integration comes as big tech firms deepen their footprint in the healthcare sector, with Apple positioned alongside peers such as MSFT, META, and GOOGL. Per market data, MSFT closed at $492.78, META at $650.33, and GOOGL at $330.52 on September 9, 2026. The partnership represents a significant new direct-to-consumer digital channel for Quest Diagnostics by leveraging Apple's extensive ecosystem.

AAPL stock stood at $315.345 at close on September 9, 2026, after reaching a day high of $319.15. Traders will be watching how this integration impacts Apple’s Services revenue growth, while specific price data for DGX was unavailable in this snapshot. According to the economic calendar, there are no major upcoming catalysts for the digital health sector in the next seven days, leaving the focus on the partnership's rollout later this year.